logoTry Persana

REPROSENT - Company Overview, Founder, CEO, Funding & Investment Details

Complete information about REPROSENT including founder details, CEO information, total funding raised, headquarters location, team size, and recent investment rounds.

REPROSENT company logo

Helping cancer patients get better outcomes using their own data.

REPROSENT helps cancer patients collect and use their own symptom data to achieve better outcomes.

HeadquartersRemote, United States
Team size1-10
Founded2020

What is REPROSENT? - Company Overview & Details

REPROSENT is REPROSENT helps cancer patients collect and use their own symptom data to achieve better outcomes. Founded in 2020, the company is headquartered in Remote, United States.

Who Founded REPROSENT?

REPROSENT was founded by Aimée DeGolyer.

Who are the Key Executives at REPROSENT? - Leadership Team

REPROSENT is led by experienced executives in key positions:

Chief Executive Officer (CEO) of REPROSENT

Aimée DeGolyerCEO

Chief Technology Officer (CTO) of REPROSENT

CTO

About Aimée DeGolyer - CEO of REPROSENT

Aimée DeGolyer serves as the Chief Executive Officer of REPROSENT, leading the company's strategic vision and operations. Connect with them on LinkedIn for professional insights.

REPROSENT Company Details & Key Information

Where is REPROSENT located?

REPROSENT is headquartered in Remote, United States.

How many employees does REPROSENT have?

REPROSENT has 1-10 employees.

When was REPROSENT founded?

REPROSENT was founded in 2020.

REPROSENT Official Website

How much funding has REPROSENT raised?

REPROSENT has raised $100,000 across 2 funding rounds. The most recent funding was completed on 2022-09-08.

Funding Overview

REPROSENT has raised a total of $100,000 through grant funding.

$100,000
Total Funding Raised
2
Funding Rounds
2022-09-08
Latest Round

REPROSENT Funding History

Grant
2022-09-08
$100,000

Who are the key investors in REPROSENT?

REPROSENT is backed by 1 key investors including Astellas Oncology C3 Prize. These investors focus on sectors.

REPROSENT Investor Overview

1
Key Investors
0
Focus Areas
0
Notable Investments

Complete List of REPROSENT Investors

Astellas Oncology C3 Prize

What sectors do REPROSENT investors focus on?

The investors backing REPROSENT primarily focus on sectors.

Featured Investor: Astellas Oncology C3 Prize

Astellas Oncology C3 Prize

Notable Investments:

What are REPROSENT's future plans?

Future Plans Information Not Available

Detailed information about REPROSENT's future plans and strategic initiatives is not currently available in our database.

What are the latest news about REPROSENT?

REPROSENT has 2 recent news updates covering key business developments and market activities.

REPROSENT News Overview

2
Recent Articles
Active
Media Coverage
2024-10-04
Latest Update

What is REPROSENT in the news for?

REPROSENT is currently featured in news for REPROSENT selected for CancerHacker Lab and other significant business developments.

Recent News Articles About REPROSENT

Article 1
2024-10-04

REPROSENT selected for CancerHacker Lab

REPROSENT has been selected as part of Cancer Patient Lab's inaugural accelerator program.

Read News
Article 2
2021-08-07

REPROSENT Launch on Product Hunt

REPROSENT launched on Product Hunt to help patients track their symptoms.

Read News

REPROSENT FAQ - Frequently Asked Questions About Founder, CEO, Funding & Company Details

Find answers to the most common questions about REPROSENT including information about founders, CEO, funding history, investors, headquarters location, and company details. 16 frequently asked questions covering key information about the company.

REPROSENT Questions & Answers - Company Information

Q1

What is REPROSENT?

REPROSENT helps cancer patients collect and use their own symptom data to achieve better outcomes.

Q2

Who founded REPROSENT?

REPROSENT was founded by Aimée DeGolyer.

Q3

Who is the CEO of REPROSENT?

The CEO of REPROSENT is Aimée DeGolyer. You can find more information about them on their LinkedIn profile.

Q4

How much funding has REPROSENT raised?

REPROSENT has raised a total of $$100,000 across 2 funding rounds. The most recent funding was completed on 2022-09-08.

Q5

Who are the investors in REPROSENT?

REPROSENT's key investors include Astellas Oncology C3 Prize.

Q6

Where is REPROSENT headquartered?

REPROSENT is headquartered in Remote, United States.

Q7

When was REPROSENT founded?

REPROSENT was founded in 2020.

Q8

How many employees does REPROSENT have?

REPROSENT has 1-10 employees.

Q9

What is REPROSENT's official website?

You can visit REPROSENT's official website at http://www.reprosent.com.

Q10

What was REPROSENT's latest funding round?

REPROSENT's latest funding round was a Grant round of $$100,000 completed on 2022-09-08.

Q11

Who is founder?

Aimée DeGolyer

Q12

What does the company do?

REPROSENT helps cancer patients collect and use their own symptom data to achieve better outcomes.

Q13

How much funding?

$100,000

Q14

Latest funding date?

2022-09-08

Q15

Who are the investors?

Astellas Oncology C3 Prize

Q16

Latest news?

REPROSENT has been selected as part of Cancer Patient Lab's inaugural accelerator program. REPROSENT launched on Product Hunt to help patients track their symptoms.

More Information About REPROSENT

For additional details about REPROSENT, including the latest news, funding updates, and company developments, explore our comprehensive company database. Find information about startup funding, company valuations, executive leadership, and business intelligence data.